Targeted therapies platform consists of the most advanced projects in Selvita’s pipeline. The main goal of this platform is to discover and further develop targeted therapies for patients with urgent and unmet medical needs in oncology with defined genetic disease profile.
Within this platform Selvita develops small molecule kinase inhibitors in the area of epigenetics and synthetic lethality concept.
- Kinase Inhibitors Projects
- Kinase Inhibitor Collaboration
- Cancer Epigenetics Projects
- Cancer Quiescence Collaboration